| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer | CEO
2 companies
Maraganore John is a Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 48 sells.
Estimated insider holdings value: $65.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2021 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 33,978 | $171.52 | $5,827,800.61 | -3.0% | -11.7% | +26.6% | |
| Aug 13, 2021 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 33,979 | $199.78 | $6,788,195.96 | -2.9% | -12.0% | +19.0% | |
| May 13, 2021 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 33,979 | $130.78 | $4,443,724.89 | -2.1% | +52.6% | -4.9% | |
| Feb 25, 2021 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 33,979 | $147.31 | $5,005,421.26 | -1.4% | -5.3% | +5.7% | |
| Nov 19, 2020 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 34,765 | $124.23 | $4,319,025.15 | -4.1% | - | - | |
| Aug 20, 2020 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 34,765 | $136.13 | $4,732,542.23 | -5.2% | - | - | |
| May 20, 2020 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 34,765 | $143.22 | $4,978,983.06 | -5.3% | - | - | |
| Feb 20, 2020 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 34,765 | $131.85 | $4,583,674.29 | -2.7% | - | - | |
| Oct 14, 2019 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 49,456 | $79.45 | $3,929,210.34 | -7.6% | - | - | |
| May 15, 2019 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 49,457 | $70.00 | $3,461,990.00 | -20.7% | - | - |